BioWorld MedTech

May 20, 2016

Breakthrough techniques tap software to reveal causes of cardiac disease

PARIS – "If we can measure it, we can manage it" would have made a better title than "Imaging and Functional Assessment" for a session at EuroPCR 2016 presenting new techniques for cardiovascular diagnostics. Read More

Studies supportive of St. Jude's devices to treat HF, prevent stroke

Myriad opens patient portal as ACLU moves on gene data complaint

Efficacy comes to phase I cancer trials

With accelerated schedule, CFDA shoots for clarity

Other news to note

Daily M&A

Appointments and advancements

Product briefs

MDD's Diagnostics Extra

Today's news in brief

BioWorld

BioWorld briefs for July 10, 2026.

FENS 2026: Next-gen biologics take on brain disease

BioWorld

Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...

FENS 2026: Shedding light on the sheddome

BioWorld

At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...

Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy

BioWorld

News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...

NRF2 activators reported in Vailima Peninsula patent

BioWorld Science

Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...